ENVIRONMENTAL TOXICOLOGY USING TRANSGENIC MOUSE MODELS
Project Number5R01ES005704-07
Contact PI/Project LeaderANDREWS, GLEN K
Awardee OrganizationUNIVERSITY OF KANSAS MEDICAL CENTER
Description
Abstract Text
DESCRIPTION (Adapted from the APPLICANT'S ABSTRACT): The overall long-term
objective of these studies is to develop and use transgenic animal model
systems to study environmental health-related issues. Specifically, our
studies focus on the metallothioneins (MTs) and transcription factors that
regulate MT genes. We propose to determine the molecular mechanisms
regulating expression of MT genes in response to cadmium (Cd) and oxidative
stresses, and the functional significance of MT in protection from oxidative
stress. Cd is a widespread environmental pollutant and many xenobiotics
cause damaging oxidative stress. MTs represent the best documented
intracellular heavy metal (Zn, Cu, Cd) binding proteins, but they can also
scavenge hydroxyl free radicals, and dismutate superoxide anions.
Transcriptional induction of the mouse MT-I gene by oxidative stress
involves activation of MTF-1 binding to metal responsive elements (MRE) in
the promoter, as well as a composite USF/antioxidant response promoter
element (USF/ARE). Preliminary evidence indicates that Cd induction is also
mediated, in part, by this element whereas Zn induction is not. Little is
known about the structure and function of MTF-1 or the USF/ARE. Transgenic
mice that over-express MT or that have targeted ablations of MT-I/MT-II gene
function have been created and will be used to examine the roles of these
proteins in protection from oxidative stress. The specific aims of this
proposal are to: 1) Determine the molecular mechanisms by which oxidative
stresses and metals activate MTF-1; 2) Explore the functional roles of the
USF/antioxidant response element in the mouse MT-I promoter during induction
by oxidative stress and Cd; 3) Examine protein interactions with the USF/ARE
during oxidative stress and Cd induction of gene expression; and 4) Analyze
resistance to oxidative stress in transgenic mice that over-express MT or
that have targeted ablations of the MT genes. Molecular (mutagenesis, EMSA,
footprinting, transfection) and biochemical (Zn titration analysis,
immunoprecipitation, binding site chromatography) approaches will be used to
define structure-function relationships for MTF-1 (Zn binding, DNA binding,
protein interactions and transactivation). Structure-function of the
USF/ARE will be defined by mutagenesis, transfection assays, and protein
binding assays. Resistance to oxidative stress in transgenic mice will be
monitored by histopathology and serum enzyme levels.
National Institute of Environmental Health Sciences
CFDA Code
113
DUNS Number
016060860
UEI
YXJGGNC5J269
Project Start Date
05-August-1991
Project End Date
30-April-2002
Budget Start Date
01-May-1998
Budget End Date
30-April-1999
Project Funding Information for 1998
Total Funding
$309,164
Direct Costs
$206,109
Indirect Costs
$103,055
Year
Funding IC
FY Total Cost by IC
1998
National Institute of Environmental Health Sciences
$309,164
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01ES005704-07
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01ES005704-07
Patents
No Patents information available for 5R01ES005704-07
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01ES005704-07
Clinical Studies
No Clinical Studies information available for 5R01ES005704-07
News and More
Related News Releases
No news release information available for 5R01ES005704-07
History
No Historical information available for 5R01ES005704-07
Similar Projects
No Similar Projects information available for 5R01ES005704-07